Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia
- PMID: 23138184
- DOI: 10.1038/leu.2012.324
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
